Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
about
Extended-spectrum beta-lactamases: a clinical updateExtended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatExtended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesDio-Sensimedia: a novel culture medium for rapid detection of extended spectrum beta-lactamasesCarbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysisCiprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistanceExtended-spectrum beta-lactamases and clinical outcomes: current data.Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.Emerging issues in antibiotic resistance in blood-borne infections.Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases.Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugsThe magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Extended-spectrum β-lactamases in Gram Negative Bacteria.Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomeDiscrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysisEmergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae.Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal.qnrB, another plasmid-mediated gene for quinolone resistanceEpidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Proteus mirabilis bacteremiaUsing interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusFluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.Resistant pathogens in respiratory tract infections in older people.Prevalence of plasmid-mediated quinolone resistance.Clinical importance and epidemiology of quinolone resistance.CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problemMolecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.Extended spectrum beta lactamase-producing Klebsiella pneumoniae infections: a review of the literature.Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Recent developments in beta lactamases and extended spectrum beta lactamases.Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae
P2860
Q24534999-C43D8AA3-A867-4D5B-8C51-8636B3BB5C2FQ24550671-07A13C20-DC8A-4F61-B0B2-EFE23384B7A2Q24650618-A237D039-7C39-4343-B65C-A38030E3744AQ24805202-1F5867B0-8C42-400C-975C-E47F74E01AF8Q27002495-B4020590-3DA9-4B9A-B62E-CB78CAD979F2Q31125417-1E92BDAE-5D80-4C79-A525-3755E990A1ABQ33236875-4A18BA35-26F2-4D0F-B5B3-39B0FA41D0FBQ33556074-C0F92B1E-2C54-457B-9360-D68BED38B757Q33601794-CDA86150-CCA8-43AD-9B6C-115D2B1B9952Q33826293-44516FEA-929A-43AC-889D-6472F9C09B5BQ33905604-FCB26779-446C-4CF6-B2F2-67CA93B3AE8CQ34078706-01DE985A-B8B8-4A3D-933E-4ABCBADF71BFQ34092336-3E4A7F4B-E871-424E-A999-0742711E0FE6Q34104453-DE8EE02A-0EE1-47CD-9093-18689950006BQ34141233-F7CC91C5-9C57-4990-8764-8C9841478C7AQ34150900-E386904E-28D5-4E23-9E32-F5246AFAE90EQ34159849-3E102536-49FE-4935-9F38-4866D16BB4BAQ34249399-230D89D4-2751-4D00-BBE5-B9D0E5C618A2Q34301565-B95F528E-ED73-4663-824E-777CC917B19EQ34336140-3E42553B-CF02-4B4B-A628-52E67BFD719FQ34351978-2D110415-5D8E-4BE6-A651-8636774C4554Q34402917-EE53FE9E-C2FA-4389-B9B9-026DFA631BB0Q34434110-AC24E3A1-C43F-401E-B385-6F5F2382AF5AQ34445641-FFF8454F-D952-4BEE-915B-402B6676E5A7Q34461810-80CF9363-70C8-4C7C-9E72-3F2570BA50B0Q34510366-2DAFA62E-60D1-4858-BB0F-7CABF6584871Q34665473-F2A7323C-91C8-4BAD-91FE-2F49D0734A26Q34680578-69F9AF36-10AE-4F7A-8693-1976B7333E19Q34680622-103AB9DA-99B9-4DB0-9CA7-CB8DCB4C8051Q34744329-8027E6E9-E6D7-4CFA-A8A4-F916B3CEF940Q34823435-D978495F-1636-48BE-A504-9BCA8BD4F541Q34838791-AF3370E1-5495-445A-AB2D-683728BB1806Q34973754-C1B23CE3-C54F-4BE4-A51D-6CEFD7B8735FQ34990058-580957C7-A50B-4B96-87A3-6B3F6E232525Q35023326-6262AE08-A62E-444B-99A1-F5F1EB6055ABQ35086696-52756081-5706-464B-999D-B341CDD2FD49Q35298431-F90C5691-6B4A-4C69-94A0-0940AAF6025FQ35356144-05FAF88E-DBB9-45D8-A69A-AEF0D503B737Q35590126-2E78F773-096B-4E48-B7CC-5635E1B4F105Q35635755-9B484A24-AA2C-43C3-A3F3-91E187932A59
P2860
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@en
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@nl
type
label
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@en
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@nl
prefLabel
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@en
Epidemiology of ciprofloxacin ...... e isolates causing bacteremia.
@nl
P2093
P2860
P356
P1476
Epidemiology of ciprofloxacin ...... ae isolates causing bacteremia
@en
P2093
Casellas JM
Goossens H
Klugman KP
McCormack JG
Mohapatra S
Mulazimoglu L
Trenholme GM
Von Gottberg A
P2860
P304
P356
10.1086/313719
P407
P577
2000-03-01T00:00:00Z